Geriatric Psychopharmacology Flashcards
list the 3 cholinesterase inhibitors
donepezil
rivastigmine
galantamine
what are the approved AD pharmacotherapies in canada
memantine
cholinesterase inhibitors
how effective are the cholinesterase inhibitors for mild to moderate AD
modestly effective
how do cholinesterase inhibitors work
stop the breakdown of acetylcholine in the synaptic cleft
how does donepezil work
NON competitive
reversible
longlasting
once a day morning dose of 5-10 mg
generally well tolerated and easy to use
how does rivastigmine work
non competitive
pseudo-irreversible
comes as a patch or capsules (BID dosing)
how is rivastigmine metabolized
almost totally INDEPENDENT of the hepatic CYP system
how does galantamine ER work
BOTH a cholinesterase inhibtor and NICOTINIC receptor modulation
COMPETITIVE inhibition
once daily dosing
side effect profile is similar to donepezil but may be better for anxiety
patients treated with cholinesterase inhibitors showed less decline on what areas of function
overall cognition
memory
naming
executive functions
ADLs
**galantamine reduces caregiver time by ONE HOUR per day in mild to moderate AD
list dementias that can be treated with cholinesterase inhibitors
mild to moderate AD
moderate to severe AD
dementia with lewy bodies
parkinsons disease dementia
vascular/mixed dementia
list 3 situations in which you would NOT prescribe a cholinesterase inhibitor
normal aging
MCI
fronto-temporal dementia (i.e bvFTD, semantic dementia, progressive nonfluent aphasia)
what % of those started on a cholinesterase inhibitor will improve noticeably
20%
what % of those started on a cholinesterase inhibitor will stay the samw
50%
what % of those started on a cholinesterase inhibitor will continue to worsen
20%
what % of those started on a cholinesterase inhibitor will be intolerant of the med
10-15%
list the side effects of cholinesterase inhibitors
GI ***
bradycardia
muscle cramps
sleep disturbance
what is one way to deal with GI SEs of cholinesterase inhibitors
change to Exelon patch
what should you do if a patient on a cholinesterase inhibitor is declining
consider alternative med when patient declining, there is caregiver dissatisfaction or there is medication intolerance
can SWITCH cholinesterase inhibitors or ADD MEMANTINE (better to add rather than switch to memenatine monotherapy)
what is the role of glutamate in AD
INCREASED activity at glutamate synapses
leads to TONIC MILD ACTIVATION at NMDA receptors
leads to neuronal death following CHRONIC INSULT and cognitive deficit due to decrease in SIGNAL TO NOISE ratio
how does memantine work
voltage dependent
low to moderate affinity
UNcompetitive NMDA receptor antagonist
acts SELECTIVELY at NMDA receptors
NO significant affinity for other receptors
how is memantine metabolized
undergoes LITTLE metabolism
majority is excreted UNCHANGED via the KIDNEYS (75-90%) with long half life (60-80 hours)
no role for cyp system
what behaviours improved with addition of memantine
agitation/aggression
irritability/lability
apathy/indifference
appetite/eating changes
when should you use memantine
moderate to severe AD–> MMSE typically under 16, needs regular prompting for basic ADLs
combined therapy with cholinesterase inhibitors preferred
useful for reducing agitation
consider in MILD AD if INTOLERANT of all cholinesterase inhibitors or they are contraindicated
do you have to adjust memantine in renal or hepatic impairment
not for hepatic
yes for renal (half of typical maintenance dose)
does memantine have significant drug interactions
no, minimal
list side effects of memantine
minimal
can have some dizziness, maybe confusion at week 4/change in bowel patterns/overactivation
how do you stage AD
by MMSE:
above 22–> mild
18-22–> mild to moderate
13-17–> moderate
8-16–> moderate to severe
less than 8–> severe
is trial discontinuation recommended for AD meds
no
why is it tricky to prescribe meds in geriatrics
- polypharmacy–> higher risk of interactions
- changes in physiology–> higher risk of SEs
- comorbidities–> higher risk of SEs
how does age impact sensitivity to benzos
the elderly have increased sensitivity to the CNS effects of benzos
why are older people at higher risk of bleeding (including as SE from meds)
greater INHIBITION of vitamin K dependent clotting factors –> increased risk of bleeding
why are the elderly at greater risk of hypotension due to meds
increased sensitivity to negative inotropic and vasodilator + diminished baroreceptor sensitivity
is there a criteria to judge potentially inappropriate medication use in older adults
Beers criteria
why do Beers criteria recommend avoiding antipsychotics in the elderly
increased risk of CVA
greater risk of cognitive decline and mortality in persons with dementia
why do the Beers criteria recommend avoiding benzos in the elderly
all increase risk of cognitive impairment, delirium, falls, fractures, and MVAs in older adults
in which cases would you consider benzos in the elderly per the Beers criteria
seizure disorders
REM sleep behaviour disorders
benzo or etoh withdrawal
severe GAD
perioperational anesthesia
do the Beers criteria recommend benztropine for treating EPS in the elderly
no–> say there are better agents
why do the Beers criteria recommend avoiding Z drugs
adverse events similar to benzos in the elderly
increased ER visits and hospitalizations
increase MVAs
minimal improvement in sleep latency and duration
list medications that may cause SIADH or hyponatremia (esp in the elderly)
antipsychotics
carbamanzepine
diuretics
mirtazapine
oxcarbazapine
SNRIs
SSRIs
TCAs
tramadol
list medications that should be avoided in older adults with, or who are at high risk for, delirium (i.e are deliriogenic)
anticholinergics
antipsychotics
benzos
corticosteroids
H2 receptor antagonists (i.e cimetidine, famotidine, ranitidine, nizatidine)
meperidine
Z drugs